Advance Your Juvenile Rheumatoid Arthritis Therapy with Worldwide
Juvenile rheumatoid arthritis – or juvenile idiopathic arthritis (JIA), as it is increasingly called – is an immune-mediated inflammatory disorder (IMIDs) whose cause and cure remain unknown. It is one of the most common chronic diseases of childhood, yet it manifests itself in at least five distinct subtypes, each of which affects different parts of a child’s body in different ways. Some children can outgrow JIA, and others endure it for a lifetime.
Is your research focused on a JIA-related therapy or intervention? To bring your work to market, you’ll need to test and refine your work through clinical trials involving children with JIA, and that poses a range of challenges. How and where will you find children with the subtype of JIA you are researching? Where will you find clinicians and facilities equipped to support the trials?
That’s where Worldwide Clinical Trials comes in. With a 30+ year track record of supporting IMID research, Worldwide is an internationally acclaimed expert in clinical trial management. We offer full-service support for Phase I-Phase IV clinical trials, as well as real-world evidence clinical research services for studies in JIA and other immune-mediated inflammatory disorders. We understand how to assemble experienced teams, how to recruit suitable research candidates, how to foster protocol compliance, and how to capture and consolidate the data that will be critical to your progress.
When it’s time for that next big step, think big. Think Worldwide.